相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of Drug-Resistant Influenza Virus A(H1N1) and A(H3N2) Variants Selected In Vitro with Laninamivir
Melanie Samson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
Sook-Kwan Leang et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2014)
Influenza H7N9 and H9N2 Viruses: Coexistence in Poultry Linked to Human H7N9 Infection and Genome Characteristics
Xinfen Yu et al.
JOURNAL OF VIROLOGY (2014)
Influenza antiviral resistance in the Asia-Pacific region during 2011
Sook-Kwan Leang et al.
ANTIVIRAL RESEARCH (2013)
Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring
Elena A. Govorkova et al.
ANTIVIRAL RESEARCH (2013)
Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance
Andrew J. Burnham et al.
ANTIVIRAL RESEARCH (2013)
Global Assessment of Resistance to Neuraminidase Inhibitors, 2008-2011: The Influenza Resistance Information Study (IRIS)
Richard J. Whitley et al.
CLINICAL INFECTIOUS DISEASES (2013)
High Severity and Fatality of Human Infections With Avian Influenza A(H7N9) Infection in China
Yuehua Ke et al.
CLINICAL INFECTIOUS DISEASES (2013)
Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses
Rubaiyea Farrukee et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Clinical use of approved influenza antivirals: therapy and prophylaxis
Michael G. Ison
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Systematic Identification of H274Y Compensatory Mutations in Influenza A Virus Neuraminidase by High-Throughput Screening
Nicholas C. Wu et al.
JOURNAL OF VIROLOGY (2013)
Oseltamivir resistance during treatment of H7N9 infection
Alan J. Hay et al.
LANCET (2013)
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
Yunwen Hu et al.
LANCET (2013)
Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections
Timothy M. Uyeki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Rongbao Gao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Neuraminidase Inhibitors for Critically Ill Children With Influenza
Janice K. Louie et al.
PEDIATRICS (2013)
New World Bats Harbor Diverse Influenza A Viruses
Suxiang Tong et al.
PLOS PATHOGENS (2013)
Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection
Norio Sugaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Long Time Scale GPU Dynamics Reveal the Mechanism of Drug Resistance of the Dual Mutant I223R/H275Y Neuraminidase from H1N1-2009 Influenza Virus
Christopher J. Woods et al.
BIOCHEMISTRY (2012)
Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs
Enguang Feng et al.
CHEMMEDCHEM (2012)
Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?
Vincent C. C. Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Influenza antivirals and resistance: the next 10 years?
Aeron C. Hurt et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Oseltamivir-resistant influenza A(H1N1) 2009 virus in Greece during the post-pandemic 2010-2011 season
Afroditi Kourti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Recovery of Influenza B Virus with the H273Y Point Mutation in the Neuraminidase Active Site from a Human Patient
Rachel R. Higgins et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A (H1N1)pdm09 Influenza in Australia
A. C. Hurt et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
Aeron C. Hurt et al.
LANCET INFECTIOUS DISEASES (2012)
Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008
Katja Bauer et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2012)
Exploring the Mechanism of Zanamivir Resistance in a Neuraminidase Mutant: A Molecular Dynamics Study
Nanyu Han et al.
PLOS ONE (2012)
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010-11
Aaron D. Storms et al.
EMERGING INFECTIOUS DISEASES (2012)
Efficacy of Single Intravenous Injection of Peramivir against Influenza B Virus Infection in Ferrets and Cynomolgus Macaques
Mitsutaka Kitano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients
Shigeru Kohno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
Adam Meijer et al.
ANTIVIRAL RESEARCH (2011)
Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution
Marie-Anne Rameix-Welti et al.
ANTIVIRAL THERAPY (2011)
Systematic review of influenza resistance to the neuraminidase inhibitors
Kristian Thorlund et al.
BMC INFECTIOUS DISEASES (2011)
Oseltamivir and Risk of Lower Respiratory Tract Complications in Patients With Flu Symptoms: A Meta-analysis of Eleven Randomized Clinical Trials
Miguel A. Hernan et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States
Jaime E. Hernandez et al.
CLINICAL INFECTIOUS DISEASES (2011)
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1
Christian Renaud et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
Andres Pizzorno et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2011)
Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza
Aeron C. Hurt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Influenza Drug Resistance
Andres Pizzorno et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses
Yacine Abed et al.
PLOS PATHOGENS (2011)
Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
Samuel B. Graitcer et al.
EMERGING INFECTIOUS DISEASES (2011)
Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010-11
Katrina Sleeman et al.
EMERGING INFECTIOUS DISEASES (2011)
Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection
Norio Sugaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance
Margaret Okomo-Adhiambo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections
Bin Wang et al.
ANTIVIRAL RESEARCH (2010)
Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double-Blind, Randomized, Noninferiority Clinical Trial
Akira Watanabe et al.
CLINICAL INFECTIOUS DISEASES (2010)
Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir
Ha T. Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2010)
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season
Tatiana Baranovich et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses
Mariana Baz et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
Aaron J. Oakley et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model
Elena A. Govorkova et al.
JOURNAL OF VIROLOGY (2010)
2009 H1N1 Influenza
Seth J. Sullivan et al.
MAYO CLINIC PROCEEDINGS (2010)
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus.
Erhard van der Vries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Jesse D. Bloom et al.
SCIENCE (2010)
Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
Adrian R. Tramontana et al.
EMERGING INFECTIOUS DISEASES (2010)
Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
Clyde Dapat et al.
EMERGING INFECTIOUS DISEASES (2010)
CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity
Makoto Yamashita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Aeron C. Hurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa
Aeron C. Hurt et al.
ANTIVIRAL RESEARCH (2009)
Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir-Resistant Influenza A(H1N1) Virus
Jairo Gooskens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
High prevalence of amantadine resistance among circulating European porcine influenza A viruses
Andi Krumbholz et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
Mariana Baz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca J. Garten et al.
SCIENCE (2009)
Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007-08
Siri H. Hauge et al.
EMERGING INFECTIOUS DISEASES (2009)
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
Tiffany G. Sheu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice
David A. Boltz et al.
ANTIVIRAL RESEARCH (2008)
The potential impact of neuraminidase inhibitor resistant influenza
Angie Lackenby et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Design of Multi-Binding-Site Inhibitors, Ligand Efficiency, and Consensus Screening of Avian Influenza H5N1 Wild-Type Neuraminidase and of the Oseltamivir-Resistant H274Y Variant
Alfonso T. Garcia-Sosa et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance
Olivier Ferraris et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors
Vanessa Escuret et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
Terry G. Besselaar et al.
EMERGING INFECTIOUS DISEASES (2008)
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
Shuji Hatakeyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza a infection in children
Norio Sugaya et al.
CLINICAL INFECTIOUS DISEASES (2007)
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J. Russell et al.
NATURE (2006)
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
Arnold S. Monto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
RA Bright et al.
LANCET (2005)
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility
HL Yen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Sensitivity performed of influenza viruses to zanamivir and oseltamivir: A study on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice
O Ferraris et al.
ANTIVIRAL RESEARCH (2005)
Current concepts - Avian influenza A (H5N1) infection in humans
H Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Resistant influenza A viruses in children treated with oseltarnivir: descriptive study
M Kiso et al.
LANCET (2004)
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
LV Gubareva
VIRUS RESEARCH (2004)
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations
L Kaiser et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
YS Babu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Resistance of influenza viruses to neuraminidase inhibitors - a review
JL McKimm-Breschkin
ANTIVIRAL RESEARCH (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
